| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.874 | 0.002 | 0.874 | Androgen antagonist | 0.804 0.002 DBMET01923 0.867 0.002 DBMET03639 | ||
| 0.415 | 0.078 | 0.415 | Analgesic | 0.388 0.09 DBMET01923 0.339 0.114 DBMET03639 | ||
| 0.251 | 0.099 | 0.251 | Ca(v)3.3 blocker | 0.231 0.132 DBMET01923 | ||
| 0.181 | 0.037 | 0.181 | Sodium channel (voltage-gated) blocker | 0.147 0.056 DBMET01923 | ||
| 0.132 | 0.004 | 0.154 | Protocollagen prolyl hydroxylase inhibitor | 0.125 0.004 DBMET01923 0.154 0.004 DBMET03639 | DBMET03639 | |
| 0.21 | 0.084 | 0.266 | HERG channel blocker | 0.266 0.06 DBMET01923 | DBMET01923 | |
| 0.142 | 0.033 | 0.142 | CDK3/cyclin E inhibitor | 0.133 0.04 DBMET01923 0.111 0.068 DBMET03639 | ||
| 0.1 | 0.002 | 0.109 | Egl nine homolog 2 inhibitor | 0.103 0.002 DBMET01923 0.109 0.002 DBMET03639 | DBMET03639 | |
| 0.192 | 0.101 | 0.221 | Potassium channel (Voltage-sensitive) blocker | 0.221 0.082 DBMET01923 | DBMET01923 | |
| 0.082 | 0.032 | 0.082 | Nav1.7 sodium channel blocker | 0.067 0.047 DBMET01923 | ||
| 0.201 | 0.164 | 0.202 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.202 0.159 DBMET01923 | DBMET01923 | |
| 0.12 | 0.084 | 0.12 | Sodium channel blocker | |||
| 0.104 | 0.08 | 0.104 | Interleukin 2 antagonist | |||
| 0.054 | 0.031 | 0.055 | Phosphodiesterase 7A inhibitor | 0.054 0.031 DBMET01923 0.055 0.03 DBMET03639 | DBMET03639 | |
| 0.151 | 0.134 | 0.151 | Potassium channel blocker | |||
| 0.056 | 0.048 | 0.056 | TRPA1 antagonist | |||
| 0.012 | 0.014 | 0.033 | Egl nine homolog 1 inhibitor | 0.033 0.004 DBMET03639 | DBMET03639 | |
| 0.026 | 0.03 | 0.028 | Dipeptidyl peptidase I inhibitor | 0.028 0.026 DBMET01923 | DBMET01923 | |
| 0.052 | 0.057 | 0.061 | Phosphodiesterase VII inhibitor | 0.061 0.046 DBMET03639 | DBMET03639 | |
| 0.03 | 0.038 | 0.037 | Kinesin antagonist | 0.037 0.025 DBMET01923 | DBMET01923 | |
| 0.03 | 0.038 | 0.037 | Kinesin-like protein 1 inhibitor | 0.037 0.025 DBMET01923 | DBMET01923 | |
| 0.006 | 0.036 | 0.012 | Egl nine homolog 3 inhibitor | 0.012 0.008 DBMET03639 | DBMET03639 | |
| 0.11 | 0.143 | 0.143 | Polo-like kinase-3 inhibitor | 0.143 0.092 DBMET01923 | DBMET01923 | |
| 0.215 | 0.254 | 0.393 | Cyclophilin D inhibitor | 0.246 0.217 DBMET01923 0.393 0.095 DBMET03639 | DBMET03639 | |
| 0.141 | 0.202 | 0.189 | MAP-kinase-activated kinase 5 inhibitor | 0.189 0.118 DBMET01923 | DBMET01923 | |
| 0.011 | 0.072 | 0.034 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.034 0.015 DBMET01923 | DBMET01923 | |
| 0.019 | 0.098 | 0.035 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.035 0.031 DBMET01923 | DBMET01923 | |
| 0.033 | 0.117 | 0.048 | Autotaxin inhibitor | 0.048 0.046 DBMET03639 | DBMET03639 | |
| 0.023 | 0.115 | 0.043 | Poly(ADP-ribose) polymerase inhibitor | 0.043 0.035 DBMET01923 | DBMET01923 | |
| 0.215 | 0.312 | 0.278 | Antiinflammatory | 0.278 0.237 DBMET03639 | DBMET03639 | |
| 0.076 | 0.267 | 0.156 | Hypolipemic | 0.156 0.13 DBMET03639 | DBMET03639 | |
| 0.089 | 0.306 | 0.129 | MAP kinase kinase 4 inhibitor | 0.129 0.118 DBMET01923 | DBMET01923 | |
| 0.141 | 0.376 | 0.198 | MAP kinase kinase 3 inhibitor | 0.198 0.129 DBMET01923 | DBMET01923 | |
| 0.019 | 0.288 | 0.099 | Check point kinase 2 inhibitor | 0.099 0.065 DBMET01923 | DBMET01923 | |
| 0.025 | 0.396 | 0.085 | Uric acid excretion stimulant | 0.085 0.074 DBMET03639 | DBMET03639 | |
| 0.006 | 0.62 | 0.044 | Retinoic acid alpha receptor agonist | 0.044 0.02 DBMET03639 | DBMET03639 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |